When federal health officials announced on Jan. 5, 2026, that they were taking six out of 17 vaccines off the childhood ...

Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% year-over-year; regulatory submission for prefilled syringe ...

Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus ...

A research team led by Václav Vopálenský and Martin Pospíšek from the Faculty of Science, Charles University, has discovered ...

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

Aurora Therapeutics has emerged from stealth with $16 million in funding from Menlo Ventures to expand the potential of gene ...